PolarityTE™ Names International Leader in Plastic and Reconstructive Surgery Dr. Maurice Nahabedian as Chief Surgical Offic...
October 06 2017 - 7:00AM
PolarityTE™, Inc. (NASDAQ:COOL) today announced the appointment of
Maurice Nahabedian, MD, FACS (http://www.mauricenahabedian.com) as
Chief Surgical Officer. Dr. Nahabedian is recognized throughout the
world for his work in breast and abdominal wall reconstruction and
holds numerous leadership positions in the field, including serving
as Vice-Chairman of this year’s meeting of the American Society of
Plastic Surgeons at “Plastic Surgery The Meeting” in Orlando, FL
from October 6-10, 2017 (www.plasticsurgerythemeeting.com), the
largest meeting of Plastic Surgeons in the country. In addition, he
will serve as Chairman of the meeting next year.
A photo accompanying this announcement is available at
http://www.globenewswire.com/NewsRoom/AttachmentNg/f7d0bfc7-cf43-4573-a2ba-c853e6849cae
“It’s humbling to bring aboard yet another world class expert in
plastic and reconstructive surgery with the addition of Dr. Maurice
Nahabedian as our Chief Surgical Officer,” stated Denver Lough, MD,
PhD, Chairman, Chief Executive Officer, and Chief Scientific
Officer of PolarityTE™. “Dr. Nahabedian has paved a path of
clinical innovation in breast and abdominal wall reconstruction and
aesthetic surgery over the past two decades, wholly recognized by
the field in his numerous appointments to elite leadership roles in
plastic and reconstructive surgery. His expertise will be
invaluable as we develop our product pipeline, expanding into fat
(AdiposeTE™) and muscle (MyoTE™) regeneration, in particular.
Furthermore, the experience and perspective of Dr. Nahabedian in
cosmetic surgery will bolster our Regenerative Aesthetics Division
and in-process development of numerous aesthetic product
derivatives from our core platform of skin, bone, fat, and muscle
regeneration.”
Lough continued, “Although we’re excited to work with Dr.
Nahabedian on all development fronts, it is uniquely intriguing to
pursue integrative applications of our autologous homologous
technology with current tissue products utilized in the areas of
breast and abdominal wall reconstruction, especially given his
long-standing working relationships with industry. Acellular dermal
matrices have greatly advanced reconstructive surgery in the breast
and abdomen, but we have envisioned taking those concepts to the
next level with our regenerative platform technology.”
Dr. Maurice Nahabedian commented, “I am honored to join the
Polarity team as Chief Surgical Officer, and I look forward to
bringing truly regenerative products to the diverse patient
population in need of answers to difficult problems. Polarity’s
approach to tissue regeneration aligns with the principles of
reconstructive surgery that have been time-tested and proven in
clinical practice, while simultaneously supplementing those
foundations with a unique take on regenerative medicine.”
Nahabedian continued, “Moreover, it is refreshing to work for a
company in the field of life sciences and healthcare not only led
by the innovator behind the technology, but also by individuals who
understand the significance of and challenges presented by the
problems they are attempting solve.”
About Maurice Nahabedian, MD, FACSMaurice
Nahabedian, MD, FACS is an attending plastic surgeon at the
National Center for Plastic Surgery in Virginia and former
Professor and Section Chief of Plastic Surgery at the MedStar
Washington Hospital Center and the Vice Chairman of the Department
of Plastic Surgery at the Georgetown University Hospital in
Washington, DC. He completed his Plastic Surgery residency at the
Johns Hopkins Hospital in 1995 and was on the plastic surgery
faculty at Johns Hopkins from 1995 – 2005 before joining the
faculty at Georgetown University in 2005. His clinical interests
include all aspects of breast surgery and abdominal wall
reconstruction. Dr. Nahabedian has been the chairman of 19
conferences throughout the United States that include the Santa Fe
Breast and Body Contouring Symposium, Aesthetica, Dueling
Perspectives in Aesthetic Surgery Symposium, Complications in
Plastic Surgery Symposium, Breast Cancer Comprehensive Conference
(BC3) and the Abdominal Wall Reconstruction Symposium. He is the
current Vice Chairman of the annual meeting program and
instructional course committee for the American Society of Plastic
Surgeons and will be the Chairman for the 2018 meeting. Dr.
Nahabedian has delivered over 1,000 lectures on topics related to
breast surgery and abdominal wall reconstruction at various local,
national, and international conferences. He has been a visiting
professor at 86 hospitals and universities since 2004. Dr.
Nahabedian has published over 200 scientific manuscripts,
editorials, and discussions, as well as 64 book chapters. He has
edited 7 textbooks on breast surgery and abdominal wall
reconstruction. Dr. Nahabedian has been the Breast Section
Editor for the Journal of Plastic and Reconstructive Surgery since
2009 and is on the editorial board of 4 other surgery journals. Dr.
Nahabedian is certified by the American Board of Plastic Surgery
and is a member of the American Society of Plastic Surgeons,
American Society for Aesthetic Plastic Surgery, American College of
Surgeons, American Association of Plastic Surgeons, and the
American Society for Reconstructive Microsurgery.
About PolarityTE™ PolarityTE™,
Inc. is a regenerative medicine company, and the first to
successfully regenerate full-thickness tissue. The Company's novel
regenerative medicine platform and proprietary technology employs a
patient's own cells for the healing of full-thickness,
functionally-polarized tissues. If clinically successful, the
PolarityTE™ platform will provide medical professionals with a
truly new paradigm in wound healing and reconstructive surgery by
utilizing a patient's own tissue substrates for the regeneration of
skin, bone, muscle, cartilage, fat, blood vessels and nerves. The
PolarityTE™ platform leverages natural and biologically-sound
principles which are readily adaptable to a wide spectrum of organ
and tissue systems. This revolutionary technology, paired with the
Company's world-renowned clinical advisory board, position
PolarityTE™ to drastically change the field and future of
translational regenerative medicine. More information can be found
online at www.PolarityTE.com.
Forward Looking StatementsCertain
statements contained in this release are "forward-looking
statements" within the meaning of the Private Securities Litigation
Reform Act of 1995. Forward looking statements contained in this
release relate to, among other things, the Company's ongoing
compliance with the requirements of The NASDAQ Stock Market and the
Company's ability to maintain the closing bid price requirements of
The NASDAQ Stock Market on a post reverse split basis. They are
generally identified by words such as "believes," "may," "expects,"
"anticipates," "should" and similar expressions. Readers should not
place undue reliance on such forward-looking statements, which are
based upon the Company's beliefs and assumptions as of the date of
this release. The Company's actual results could differ materially
due to risk factors and other items described in more detail in the
"Risk Factors" section of the Company's Annual Reports and other
filings with the SEC (copies of which may be obtained at
www.sec.gov). Subsequent events and developments may cause these
forward-looking statements to change. The Company specifically
disclaims any obligation or intention to update or revise these
forward-looking statements as a result of changed events or
circumstances that occur after the date of this release, except as
required by applicable law.
Contacts:
Scott
SantiamoRussoPartnersLLCScott.Santiamo@RussoPartnersLLC.com (718)
344-5843
David SchullRussoPartnersLLCDavid.Schull@RussoPartnersLLC.com
(858) 717-2310
Corner Growth Acquisition (NASDAQ:COOL)
Historical Stock Chart
From Apr 2024 to May 2024
Corner Growth Acquisition (NASDAQ:COOL)
Historical Stock Chart
From May 2023 to May 2024